Published online May 16, 2017. doi: 10.12998/wjcc.v5.i5.172
Peer-review started: October 10, 2016
First decision: December 1, 2016
Revised: December 8, 2016
Accepted: February 28, 2017
Article in press: March 2, 2017
Published online: May 16, 2017
To evaluate the feasibility, safety and peri- and postoperative outcomes of robotic single-site supracervical hysterectomy (RSSSH) for benign gynecologic disease.
We report 3 patients who received RSSSH for adenomyosis of the uterus from November 2015 to April 2016. We evaluated the feasibility, safety and outcomes among these patients.
The mean surgical time was 244 min and the estimated blood loss was 216 mL, with no blood transfusion necessitated. The docking time was shortened gradually from 30 to 10 min. We spent 148 min on console operation. Manual morcellation time was also short, ranging from 5 to 10 min. The mean hospital stay was 5 d. Lower VAS pain score was also noted. There is no complication during or after surgery.
RSSSH is feasible and safe, incurs less postoperative pain and gives good cosmetic appearance. The technique of in-bag, manual morcellation can avoid tumor dissemination.
Core tip: Robotic single-site surgery (RSS) is feasible and safe in performing supracervical hysterectomy for benign gynecologic disease. Less pain and cosmetic value are important advantages of RSS. Manual morcellation can be done through single port setting.